Sort
48,018 grants matching “immunotherapy”
Molecular Basis of Parvoviral Target Cell Specificity
$486,449Peter Tattersall · Yale University · R01 · FY2011 · CA
Immunotherapy of KPC Infection
$486,421Jay K Kolls · Tulane University Of Louisiana · R01 · FY2023 · AI
Immunotherapy of KPC Infection
$486,421Jay K Kolls · Tulane University Of Louisiana · R01 · FY2020 · AI
Immunotherapy of KPC Infection
$486,421Jay K Kolls · Tulane University Of Louisiana · R01 · FY2021 · AI
Immunotherapy of KPC Infection
$486,421Jay K Kolls · Tulane University Of Louisiana · R01 · FY2022 · AI
Tumor cell metabolism in action
$486,290Eileen White · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA
Characterization of Biological Nanoparticle Subsets
$486,284Jennifer Jones · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Cell-targeted glutamine antagonists as a novel therapy for lymphoma
$486,249Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2022 · CA
Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model
$486,226David R Grosshans · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Studies of Human T Regulatory Cells
$486,201Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Metabolic and molecular regulation of myeloid cell functions in brain cancer
$486,185Filippo Veglia · Wistar Institute · R01 · FY2024 · NS
Project-003
$486,160Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2021 · CA
A Novel Device for Determination of GFR Markers
$486,108Bikas Vaidya · Lynntech, Inc. · R44 · FY2008 · DK
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
$486,085Lily Yang · Emory University · R01 · FY2021 · CA
A multipronged, mRNA gene therapy approach to HIV cure
$486,057Edward Kreider · University Of Pennsylvania · DP2 · FY2025 · AI
Transcriptional Control of Natural Killer Cell Development
$486,000Barbara Lynne Kee · University Of Chicago · R01 · FY2020 · AI
Transcriptional Control of Natural Killer Cell Development
$486,000Barbara Lynne Kee · University Of Chicago · R01 · FY2022 · AI
Transcriptional Control of Natural Killer Cell Development
$486,000Barbara Lynne Kee · University Of Chicago · R01 · FY2019 · AI
Transcriptional Control of Natural Killer Cell Development
$486,000Barbara Lynne Kee · University Of Chicago · R01 · FY2021 · AI
Transcriptional Control of Natural Killer Cell Development
$486,000Barbara Lynne Kee · University Of Chicago · R01 · FY2023 · AI
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$485,992William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
T Cell Immunity in Endemic Burkitt Lymphoma
$485,971Ann M Moormann · Case Western Reserve University · R01 · FY2008 · CA
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
$485,968Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
TCR engineering of human T cells for immunotherapy of hepatocellular carcinoma
$485,965Yukai He · Augusta University · R01 · FY2019 · CA
Project 2:Nanoparticle-based Immune Modulators in Cancer Therapy & Vaccines
$485,906Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U54 · FY2016 · CA